BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 10547551)

  • 1. Correlation of margin status and extraprostatic extension with progression of prostate carcinoma.
    Cheng L; Darson MF; Bergstralh EJ; Slezak J; Myers RP; Bostwick DG
    Cancer; 1999 Nov; 86(9):1775-82. PubMed ID: 10547551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of positive surgical margins in patients with extraprostatic carcinoma after radical prostatectomy.
    Kausik SJ; Blute ML; Sebo TJ; Leibovich BC; Bergstralh EJ; Slezak J; Zincke H
    Cancer; 2002 Sep; 95(6):1215-9. PubMed ID: 12216087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anatomic site-specific positive margins in organ-confined prostate cancer and its impact on outcome after radical prostatectomy.
    Blute ML; Bostwick DG; Bergstralh EJ; Slezak JM; Martin SK; Amling CL; Zincke H
    Urology; 1997 Nov; 50(5):733-9. PubMed ID: 9372884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
    Kupelian PA; Katcher J; Levin HS; Klein EA
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of prostate carcinoma death in patients with lymph node metastasis.
    Cheng L; Zincke H; Blute ML; Bergstralh EJ; Scherer B; Bostwick DG
    Cancer; 2001 Jan; 91(1):66-73. PubMed ID: 11148561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma.
    Gettman MT; Pacelli A; Slezak J; Bergstralh EJ; Blute M; Zincke H; Bostwick DG
    Urology; 1999 Sep; 54(3):479-85. PubMed ID: 10475358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer.
    Kupelian P; Katcher J; Levin H; Zippe C; Klein E
    Urology; 1996 Aug; 48(2):249-60. PubMed ID: 8753737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative prediction of surgical margin status in patients with prostate cancer treated by radical prostatectomy.
    Cheng L; Slezak J; Bergstralh EJ; Myers RP; Zincke H; Bostwick DG
    J Clin Oncol; 2000 Aug; 18(15):2862-8. PubMed ID: 10920134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of extraprostatic extension of prostate cancer based on needle biopsy findings: perineural invasion lacks significance on multivariate analysis.
    Egan AJ; Bostwick DG
    Am J Surg Pathol; 1997 Dec; 21(12):1496-500. PubMed ID: 9414194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic implications of positive margins in radical prostatectomy specimens].
    Ojea Calvo A; González Piñeiro A; Domínguez Freire F; Alonso Rodrigo A; Rodríguez Iglesias B; Benavente Delgado J
    Actas Urol Esp; 2005; 29(7):641-56. PubMed ID: 16180314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic indicators in patients with seminal vesicle involvement following radical prostatectomy for clinically localized prostate cancer.
    Tefilli MV; Gheiler EL; Tiguert R; Banerjee M; Sakr W; Grignon DJ; Pontes JE; Wood DP
    J Urol; 1998 Sep; 160(3 Pt 1):802-6. PubMed ID: 9720552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome after radical prostatectomy with a pretreatment prostate biopsy Gleason score of >/=8.
    Manoharan M; Bird VG; Kim SS; Civantos F; Soloway MS
    BJU Int; 2003 Oct; 92(6):539-44. PubMed ID: 14511029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial prostate cancer: a different disease?
    Kupelian PA; Klein EA; Witte JS; Kupelian VA; Suh JH
    J Urol; 1997 Dec; 158(6):2197-201. PubMed ID: 9366343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy.
    Blute ML; Bergstralh EJ; Iocca A; Scherer B; Zincke H
    J Urol; 2001 Jan; 165(1):119-25. PubMed ID: 11125379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
    Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
    Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens.
    Eastham JA; Kattan MW; Riedel E; Begg CB; Wheeler TM; Gerigk C; Gonen M; Reuter V; Scardino PT
    J Urol; 2003 Dec; 170(6 Pt 1):2292-5. PubMed ID: 14634399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting prostate carcinoma volume and stage at radical prostatectomy by assessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, Gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen: a report of 454 cases.
    Sebo TJ; Cheville JC; Riehle DL; Lohse CM; Pankratz VS; Myers RP; Blute ML; Zincke H
    Cancer; 2001 Jun; 91(11):2196-204. PubMed ID: 11391602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining the cut-off values of tumor diameter, degree of extraprostatic extension, and extent of surgical margin positivity with regard to biochemical recurrence of prostate cancer after radical prostatectomy.
    Kir G; Arikan EA; Seneldir H; Ankarali H; Oznergiz S; Olgun ZC; Yildirim A
    Ann Diagn Pathol; 2020 Feb; 44():151431. PubMed ID: 31837592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between the extent of extraprostatic extension and survival following radical prostatectomy.
    Jeong BC; Chalfin HJ; Lee SB; Feng Z; Epstein JI; Trock BJ; Partin AW; Humphreys E; Walsh PC; Han M
    Eur Urol; 2015 Feb; 67(2):342-6. PubMed ID: 24968968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.